Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Cells held three times as long in 'delayed crosslinking' microgel tech

Dutch scientists have developed a microgel chip that is capable of holding single cells for analysis and research for far longer than currently available 3D culturing technologies.

DIA 2017

RBM adoption driving growth as CROS NT evolves service offering

CROS NT has announced a new clinical trial solution that enables sponsors to take a risk-based approach to site monitoring – a shift to which is driving company growth, says CEO.

Evotec: patient biobank access to advance drug discovery

Evotec has joined a consortium through which it gains access to a sample biobank in order to perform drug discovery based on unique kidney disease patient cohorts.

Avista supporting cGMP manufacture of hapten for opioid vaccine development

Avista Pharma Solutions, Inc. has been contracted to manufacture an opioid-derived small molecule, which is a component of a conjugate vaccine being developed to treat opioid addiction.  


How to prepare for ICH E6 R2 implementation

ICH E6 (R2) modernizes the ICH Good Clinical Practice (GCP) Guideline, which was implemented more than 20 years ago.

Promotional Features

Key Industry Events


Access all events listing

Our events, Shows & Conferences...